Jose M. Mesa

Array ( [id] => 7290815 [patent_doc_number] => 20040110699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of ABCC2 expression' [patent_app_type] => new [patent_app_number] => 10/316389 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21747 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110699.pdf [firstpage_image] =>[orig_patent_app_number] => 10316389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865554 [patent_doc_number] => 20030191080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Antisense compositions targeted to beta1-adrenoceptor-specific mRNA and methods of use' [patent_app_type] => new [patent_app_number] => 10/308503 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 40508 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191080.pdf [firstpage_image] =>[orig_patent_app_number] => 10308503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856715 [patent_doc_number] => 20030130216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease' [patent_app_type] => new [patent_app_number] => 10/203333 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9117 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130216.pdf [firstpage_image] =>[orig_patent_app_number] => 10203333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829698 [patent_doc_number] => 20030180756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Compositions and methods for suppressing eukaryotic gene expression' [patent_app_type] => new [patent_app_number] => 10/301516 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27514 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180756.pdf [firstpage_image] =>[orig_patent_app_number] => 10301516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364338 [patent_doc_number] => 20040005581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Human vanilloid receptor protein and polynucleotide sequence encoding same' [patent_app_type] => new [patent_app_number] => 10/301477 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9648 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005581.pdf [firstpage_image] =>[orig_patent_app_number] => 10301477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697286 [patent_doc_number] => 20030109480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Inhibitors of endothelin-1 synthesis' [patent_app_type] => new [patent_app_number] => 10/295942 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8170 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109480.pdf [firstpage_image] =>[orig_patent_app_number] => 10295942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660170 [patent_doc_number] => 20030134814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Method of using 18080, a human serine carboxypeptidase family member' [patent_app_type] => new [patent_app_number] => 10/294039 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 48443 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134814.pdf [firstpage_image] =>[orig_patent_app_number] => 10294039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658840 [patent_doc_number] => 07105657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Compositions and methods for inhibiting pancreatic cancer metastasis' [patent_app_type] => utility [patent_app_number] => 10/291151 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9367 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105657.pdf [firstpage_image] =>[orig_patent_app_number] => 10291151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801620 [patent_doc_number] => 20030096785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Control of hunger, satiety, and food intake by modulating expression and activity of cephalic G protein-coupled receptors' [patent_app_type] => new [patent_app_number] => 10/287224 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13386 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096785.pdf [firstpage_image] =>[orig_patent_app_number] => 10287224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739661 [patent_doc_number] => 20030157030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => ' METHODS AND COMPOSITIONS FOR THERAPEUTIC USE OF RNA INTERFERENCE\n ' [patent_app_type] => original-publication-amended [patent_app_number] => 10/288230 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21593 [patent_no_of_claims] => 212 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157030.pdf [firstpage_image] =>[orig_patent_app_number] => 10288230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792528 [patent_doc_number] => 20030087872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616' [patent_app_type] => new [patent_app_number] => 10/283013 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32144 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087872.pdf [firstpage_image] =>[orig_patent_app_number] => 10283013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852035 [patent_doc_number] => 20030144238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Nucleic acids, polypeptides, and methods for modulating apoptosis' [patent_app_type] => new [patent_app_number] => 10/277969 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 24278 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144238.pdf [firstpage_image] =>[orig_patent_app_number] => 10277969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166945 [patent_doc_number] => 20040077082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'RNA-based inhibitory oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/273678 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9655 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077082.pdf [firstpage_image] =>[orig_patent_app_number] => 10273678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835156 [patent_doc_number] => 20030162702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Compositions and methods for altering cell migration' [patent_app_type] => new [patent_app_number] => 10/270871 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7926 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162702.pdf [firstpage_image] =>[orig_patent_app_number] => 10270871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7439811 [patent_doc_number] => 20040009156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/269021 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17168 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009156.pdf [firstpage_image] =>[orig_patent_app_number] => 10269021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843630 [patent_doc_number] => 20030148977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Oligonucleotides antisense to rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation' [patent_app_type] => new [patent_app_number] => 10/262258 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25457 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148977.pdf [firstpage_image] =>[orig_patent_app_number] => 10262258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783483 [patent_doc_number] => 20030064931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Metabolic genes and related methods and compositions' [patent_app_type] => new [patent_app_number] => 10/260994 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10600 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064931.pdf [firstpage_image] =>[orig_patent_app_number] => 10260994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7203414 [patent_doc_number] => 20050042752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Methods of inducing gene expression' [patent_app_type] => utility [patent_app_number] => 10/490489 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8563 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042752.pdf [firstpage_image] =>[orig_patent_app_number] => 10490489 [rel_patent_id] =>[rel_patent_doc_number] =>)